Denise L. Blomquist's most recent trade in Medtronic Plc was a trade of 246 Ordinary Shares done . Disclosure was reported to the exchange on Aug. 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 246 | 12,671 (0%) | 0% | 0 | Ordinary Shares | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 246 | 0 | - | - | Performance Share Unit | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 214 | 0 | - | - | Stock Option (Right to Buy) | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.00 per share. | 01 Aug 2025 | 214 | 12,624 (0%) | 0% | 78 | 16,692 | Ordinary Shares |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. | 01 Aug 2025 | 204 | 12,410 (0%) | 0% | 89.3 | 18,225 | Ordinary Shares |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. | 01 Aug 2025 | 196 | 12,428 (0%) | 0% | 89.3 | 17,511 | Ordinary Shares |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.34 per share. | 01 Aug 2025 | 93 | 12,578 (0%) | 0% | 89.3 | 8,309 | Ordinary Shares |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 58 | 12,636 (0%) | 0% | 0 | Ordinary Shares | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 58 | 0 | - | - | Performance Share Unit | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.32 per share. | 01 Aug 2025 | 22 | 12,614 (0%) | 0% | 89.3 | 1,965 | Ordinary Shares |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2025 | 2,202 | 2,202 | - | - | Performance Share Units | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2025 | 2,202 | 12,425 (0%) | 0% | 0 | Ordinary Shares | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2025 | 1,278 | 1,278 | - | - | Stock Option (Right to Buy) | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2025 | 310 | 10,143 (0%) | 0% | 0 | Ordinary Shares | |
Medtronic | Denise L. Blomquist | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2025 | 2,975 | 10,453 (0%) | 0% | 0 | Ordinary Shares |